Patents by Inventor Junya Kase

Junya Kase has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC AGENT FOR ANXIETY DISORDERS
    Publication number: 20200247798
    Abstract: Provided are an agent for the treatment and/or prophylaxis of an anxiety disorder comprising, as an active ingredient, a thiazole derivative represented by the formula (I) wherein R1 represents aryl or the like, and R2 represents pyridyl or the like, or a pharmaceutically acceptable salt thereof, and the like.
    Type: Application
    Filed: April 21, 2020
    Publication date: August 6, 2020
    Inventors: Junya Kase, Tomoyuki Kanda
  • THERAPEUTIC AGENT FOR ANXIETY DISORDERS
    Publication number: 20200002327
    Abstract: Provided are an agent for the treatment and/or prophylaxis of an anxiety disorder comprising, as an active ingredient, a thiazole derivative represented by the formula (I) wherein R1 represents aryl or the like, and R2 represents pyridyl or the like, or a pharmaceutically acceptable salt thereof, and the like.
    Type: Application
    Filed: September 12, 2019
    Publication date: January 2, 2020
    Inventors: Junya Kase, Tomoyuki Kanda
  • THERAPEUTIC AGENT FOR ANXIETY DISORDERS
    Publication number: 20150080415
    Abstract: Provided are an agent for the treatment and/or prophylaxis of an anxiety disorder comprising, as an active ingredient, a thiazole derivative represented by the formula (I) wherein R1 represents aryl or the like, and R2 represents pyridyl or the like, or a pharmaceutically acceptable salt thereof, and the like.
    Type: Application
    Filed: November 25, 2014
    Publication date: March 19, 2015
    Inventors: Junya Kase, Tomoyuki Kanda
  • Method of treating an anxiety disorder
    Patent number: 8592420
    Abstract: Anxiety disorders, such as panic disorder, agoraphobia, obsessive-compulsive disorder, social phobia, post-traumatic stress disorder, generalized anxiety disorder, specific phobia, or the like, are treated by administering an effective amount of at least one adenosine A2A receptor antagonist to a patient in need thereof, optionally in combination with an anxiolytic(s) other than the adenosine A2A receptor antagonist.
    Type: Grant
    Filed: April 16, 2012
    Date of Patent: November 26, 2013
    Assignee: Kyowa Hakko Kirin Co., Ltd.
    Inventors: Hiroshi Kase, Naoki Seno, Shizuo Shiozaki, Minoru Kobayashi, Junya Kase
  • METHOD OF TREATING AN ANXIETY DISORDER
    Publication number: 20120232089
    Abstract: Anxiety disorders, such as panic disorder, agoraphobia, obsessive-compulsive disorder, social phobia, post-traumatic stress disorder, generalized anxiety disorder, specific phobia, or the like, are treated by administering an effective amount of at least one adenosine A2A receptor antagonist to a patient in need thereof, optionally in combination with an anxiolytic(s) other than the adenosine A2A receptor antagonist.
    Type: Application
    Filed: April 16, 2012
    Publication date: September 13, 2012
    Applicant: KYOWA HAKKO KIRIN CO., LTD.
    Inventors: Hiroshi Kase, Naoki Seno, Shizuo Shiozaki, Minoru Kobayashi, Junya Kase
  • THERAPEUTIC AGENT FOR ANXIETY DISORDERS
    Publication number: 20120172362
    Abstract: Provided are an agent for the treatment and/or prophylaxis of an anxiety disorder comprising, as an active ingredient, a thiazole derivative represented by the formula (I) wherein R1 represents aryl or the like, and R2 represents pyridyl or the like, or a pharmaceutically acceptable salt thereof, and the like.
    Type: Application
    Filed: September 2, 2010
    Publication date: July 5, 2012
    Applicant: KYOWA HAKKO KIRIN CO., LTD.
    Inventors: Junya Kase, Tomoyuki Kanda
  • Method of treating an anxiety disorder
    Patent number: 8202869
    Abstract: Anxiety disorders, such as panic disorder, agoraphobia, obsessive-compulsive disorder, social phobia, post-traumatic stress disorder, generalized anxiety disorder, specific phobia, or the like, are treated by administering an effective amount of at least one adenosine A2A receptor antagonist to a patient in need thereof, optionally in combination with an anxiolytic(s) other than the adenosine A2A receptor antagonist.
    Type: Grant
    Filed: June 10, 2004
    Date of Patent: June 19, 2012
    Assignee: Kyowa Hakko Kirin Co., Ltd.
    Inventors: Hiroshi Kase, Naoki Seno, Shizuo Shiozaki, Minoru Kobayashi, Junya Kase
  • Method of treating an anxiety disorder
    Publication number: 20060281770
    Abstract: Anxiety disorders, such as panic disorder, agoraphobia, obsessive-compulsive disorder, social phobia, post-traumatic stress disorder, generalized anxiety disorder, specific phobia, or the like, are treated by administering an effective amount of at least one adenosine A2A receptor antagonist to a patient in need thereof, optionally in combination with an anxiolytic(s) other than the adenosine A2A receptor antagonist.
    Type: Application
    Filed: June 10, 2004
    Publication date: December 14, 2006
    Applicant: Kyowa Hakko Kogyo Co. Ltd
    Inventors: Hiroshi Kase, Naoki Seno, Shizuo Shiozaki, Minoru Kobayashi, Junya Kase